Patent Expiry
PBYI: NERLYNX: recorded patent 8669273 expiry
July 18, 2031 · NERATINIB MALEATE. BioSniper AI can trace the company-impact path without requiring you to write the research question.
- Event date
- July 18, 2031
- Company
- PUMA BIOTECHNOLOGY, INC. (PBYI)
- Drug
- NERATINIB MALEATE
BioSniper AIPage evidence connected
Prepared research question
What could this event change, and which evidence should be watched next?
Run cited research
Traceable citations · Unknowns marked
Patent Expiry
NERLYNX: recorded patent 8669273 expiry
Orange Book application NDA208051, product 001, listed patent 8669273 expiry. Overall loss of exclusivity and current company rights: unknown.FDA source